LONDON: A landmark report published in The Lancet Diabetes & Endocrinology and supported by 75 global medical organizations proposes a paradigm shift in the way obesity is diagnosed, moving beyond the traditional body mass index (BMI). Led by Professor Francesco Rubino of King’s College London, the Commission introduces a new, personalized framework that considers other measures of excess body fat and individual health conditions to determine when obesity should be classified as a disease.
The Commission’s findings aim to address significant gaps in clinical practice, where reliance on BMI often leads to misdiagnosis or missed health risks. With over a billion people worldwide living with obesity, the proposed definition distinguishes between "clinical obesity" — marked by organ dysfunction or reduced daily function — and "pre-clinical obesity," characterized by excess fat without immediate health complications but elevated future disease risk.
According to Rubino, “Obesity should not be viewed as an all-or-nothing condition. Personalized care is essential — some individuals with high BMI remain healthy, while others experience severe health issues due to fat distribution around critical organs.”
The new diagnostic criteria recommend waist circumference and waist-to-hip ratio alongside BMI, or direct body fat measurements using DEXA scans, to provide a more precise evaluation of obesity-related risks. For those with clinical obesity, evidence-based treatments, including lifestyle changes, medications, and surgery, should be tailored based on individual benefit-risk assessments. In contrast, risk reduction and preventive counseling are recommended for individuals with pre-clinical obesity.
Commissioner Professor Robert Eckel highlights, “BMI alone fails to account for fat distribution. Central fat around the waist or organs carries higher risks, often missed by BMI-based diagnosis.”
The report emphasizes that health insurers should recognize clinical obesity as a chronic disease deserving standalone coverage, eliminating the need for comorbid conditions like type 2 diabetes to justify treatment. Additionally, addressing societal stigma and improving training for healthcare professionals are critical to effective obesity management.
The Commission’s groundbreaking recommendations offer a transformative pathway for healthcare systems to adopt more nuanced, evidence-based, and resource-efficient approaches to obesity care, benefiting millions worldwide.
As global obesity rates continue to soar, the adoption of this new framework promises not only improved health outcomes but also a reduction in healthcare costs by preventing unnecessary treatments and focusing on targeted, personalized care.